Multiple Ileal and Colonic Stenoses: Is It Always Crohn’s Disease?

• by Sarah Bencardino, Mariangela Allocca, Federica Furfaro, Ferdinando D’Amico, Tommaso Lorenzo Parigi, Silvio Danese, Alessandra Zilli

• December 16, 2024

Successful reversal of hepatic visceral crisis in HER2-positive metastatic breast cancer: a case report

• by Joan Manuel Moreno Luján, Jorge Luis Soriano Lorenzo, Miguel Martínez Rubiño, Sònia Servitja Tormo, Tamara Martos Cárdenas, María Martínez García, Joan Albanell Mestres

• May 22, 2026

Dynamic changes and clinical significance of the gut microbiota and serum metabolites in breast cancer onset, progression and chemotherapy intervention

• by Shuyun Jiang, Zhanwei Du, Yufei Wang, Hongwei Ma, Zhijun Ma, Xiaowang Wang

• May 14, 2026

Addressing Tamoxifen-Associated Weight Gain: Lifestyle and Pharmacotherapy Options

Tamoxifen is commonly prescribed in hormone receptor-positive breast cancer but also associated with weight gain, which can complicate survivorship care. This narrative review summarizes evidence on tamoxifen-associated weight gain and outlines pharmacologic weight management options in this population.

• by Latonya Fore-Williams, Michele Distler

• May 13, 2026

• 13 min